Revelation Biosciences, Inc. · NASDAQ:REVB
Armistice Capital, LLC's stake in Revelation Biosciences, Inc. fell to 4.99% (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 14, 2026
Armistice Capital, LLC's stake in Revelation Biosciences, Inc. fell to 4.99%, 209,212 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).
- Stake
- 4.99%
- Shares
- 209,212
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Armistice Capital, LLC | 4.99% | 209,212 |
| Steven Boyd | 4.99% | 209,212 |
Source
Related
- Revelation Biosciences, Inc.
- Armistice Capital, LLC
- Revelation Biosciences, Inc. shareholders
- Schedule 13G · Armistice Capital, LLC · May 15, 2026
- Form 4 · Rolke James · Aug 18, 2026
- Form 4 · Chawla Lakhmir S · Aug 18, 2026
- Form 4 · Zygmont Chester Stanley III · Aug 18, 2026
- Form 4 · Roper Jess · Aug 18, 2026
- Form 4 · Carver Jennifer · Aug 18, 2026